PIQUR Therapeutics AG - Company Review
PIQUR Therapeutics AG - Company ReviewSummary
PIQUR Therapeutics AG (PIQUR) is a clinical-stage pharmaceutical company that discovers and develops anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipeline products include PQR-309, PQR-620, PQR-530, PQR-514, PQR-6XX, and PI3K/mTOR inhibitors. PIQUR’s lead compound PQR309, is a potent small molecule with balanced pan-PI3K/mTOR selectivity. The company’s target therapy areas include oncology, central nervous system, ophthalmology, and dermatology, among others. It conducts research in the areas of oncology. PIQUR serves patients and the medical community. The company partners with pharmaceutical and biotech companies. PIQUR is headquartered in Basel, Switzerland.
This comprehensive company report of PIQUR Therapeutics AG provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.